BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 9756019)

  • 1. AgNORs in duct epithelial lesions in chronic pancreatitis and in pancreas cancer cells.
    Cylwik B; Nowak HF; Puchalski Z; Zimnoch L; Dadan J
    Hepatogastroenterology; 1998; 45(22):1130-4. PubMed ID: 9756019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial anomalies in chronic pancreatitis as a risk factor of pancreatic cancer.
    Cylwik B; Nowak HF; Puchalski Z; Barczyk J
    Hepatogastroenterology; 1998; 45(20):528-32. PubMed ID: 9638443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphological lesions associated with human primary invasive nonendocrine pancreas cancer.
    Cubilla AL; Fitzgerald PJ
    Cancer Res; 1976 Jul; 36(7 PT 2):2690-8. PubMed ID: 1277176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleolar organizer regions in exocrine pancreas in chronic pancreatitis and ductal adenocarcinoma. Diagnostic value and cytophysiologic correlate.
    Pollok A
    Gen Diagn Pathol; 1997 Feb; 142(3-4):199-209. PubMed ID: 9065584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular carcinoma and preneoplastic lesions of the liver: evaluation of argyrophilic nucleolar organizer regions (AgNORs).
    Bufo P; Frassanito F
    Boll Soc Ital Biol Sper; 1992 Nov; 68(11):707-14. PubMed ID: 1338418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Image analysis of AgNORs in esophageal balloon cytosmears].
    Wang DY
    Zhonghua Zhong Liu Za Zhi; 1993 Jan; 15(1):30-3. PubMed ID: 8334937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silver-stained nucleolar organizer regions and immunoglobulins in cutaneous squamocellular tumors.
    Aroni K; Mastoraki A; Kyriazi E; Liossi A; Ioannidis E
    Pathol Res Pract; 2007; 203(12):857-62. PubMed ID: 17949923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Argyrophilic nucleolar organizer regions may help the differential diagnostic distinction between chronic pancreatitis and pancreatic ductal adenocarcinoma.
    Mäkinen K; Eskelinen M; Lipponen P; Pasanen P; Nuutinen P; Alhava E
    Scand J Gastroenterol; 1994 Nov; 29(11):1029-33. PubMed ID: 7871369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Morphologic, morphometric and immunohistochemical studies on pancreatic intraductal hyperplasia and infiltrating carcinoma].
    Tomaszewska R
    Folia Med Cracov; 1999; 40(1-2):101-41. PubMed ID: 10909469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sialylated MUC1 mucin expression in normal pancreas, benign pancreatic lesions, and pancreatic ductal adenocarcinoma.
    Masaki Y; Oka M; Ogura Y; Ueno T; Nishihara K; Tangoku A; Takahashi M; Yamamoto M; Irimura T
    Hepatogastroenterology; 1999; 46(28):2240-5. PubMed ID: 10521973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ductal epithelial lesions and pancreatic adenocarcinoma].
    Bentjerodt R; Smok G
    Rev Med Chil; 1990 Oct; 118(10):1099-104. PubMed ID: 2152626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lesions of the pancreatic duct epithelium and histogenesis of exocrine pancreatic carcinomas].
    Schulz HJ
    Zentralbl Pathol; 1994 Aug; 140(3):203-10. PubMed ID: 7947629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How many millimeters do atypical epithelia of the pancreas spread intraductally before beginning to infiltrate?
    Kimura W
    Hepatogastroenterology; 2003; 50(54):2218-24. PubMed ID: 14696502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histogenesis of pancreatic carcinomas: a study based on 248 cases.
    Chen J; Baithun SI; Ramsay MA
    J Pathol; 1985 May; 146(1):65-76. PubMed ID: 4009323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinico-pathological and histochemical studies on hypertrophic duct epithelium in human non-endocrine pancreas cancer.
    Hisata Y
    Bull Tokyo Med Dent Univ; 1979 Jun; 26(2):139-48. PubMed ID: 87280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the number of silver-stained nucleolar organizer regions in the normal, preneoplastic, and neoplastic endometrium.
    Niwa K; Murase T; Morishita S; Tanaka T; Shimokawa K; Tamaya T
    Cancer Detect Prev; 1995; 19(5):436-40. PubMed ID: 7585730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on proliferating potential by Ag-NORs staining in human pancreatic carcinoma].
    Aimoto T; Onda M; Uchida E; Asano G
    Nihon Geka Gakkai Zasshi; 1993 Jan; 94(1):78-85. PubMed ID: 8437556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AgNOR counts in preneoplastic lesions of the bronchus.
    Fisseler-Eckhoff A; Becker T; Sudhoff H; Müller KM
    Pathol Res Pract; 1994 Apr; 190(4):389-93. PubMed ID: 8078808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleolar organizer regions (AgNORs) in in situ and invasive components of breast cancers.
    Răşinaru A; Olinici CD; Blaga ML
    Rom J Morphol Embryol; 1994; 40(1-2):7-10. PubMed ID: 7640380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dysplasia and carcinoma in situ of the pancreatic duct epithelium].
    Schulz HJ
    Zentralbl Allg Pathol; 1988; 134(1):3-14. PubMed ID: 2833841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.